d-Arabitol Ameliorates Obesity and Metabolic Disorders via the Gut Microbiota-SCFAs-WAT Browning Axis.

Abstract

d-Arabitol, which is typically found in mushrooms, lichens, and higher fungi, might play an effective role in alleviating visceral fat accumulation and insulin resistance particularly for its low calorie and glycemic index. However, the regulatory mechanisms of d-arabitol for alleviating obesity and associated metabolic disorders remain poorly understood. This study aimed to investigate and analyze the underlying relationship between d-arabitol-mediated gut microbiota and obesity. The results showed that d-arabitol dramatically ameliorated body weight gain, fat accumulation, and insulin resistance in HFD-fed rats. Likewise, d-arabitol remarkably increased the relative abundance of the genera Blautia, Anaerostipes, and Phascolarctobacterium and decreased the genera Romboutsia and Clostridium_sensu_stricto_1. Furthermore, these alterations in gut microflora increased SCFAs, which in turn indirectly promoted AMPK-PGC-1α-related white adipose tissue (WAT) browning. Therefore, d-arabitol would have the potential to alleviate obesity through the gut microbiota-SCFAs-WAT browning axis. It could be considered as a sugar substitute for the obese population and diabetic patients.

• Authors: Xiaolan Li, Jian Huang, Junhua Yun, Guoyan Zhang, Yufei Zhang, Mei Zhao, Hossain M Zabed, Yuvaraj Ravikumar, Xianghui Qi
• Journal: Journal of agricultural and food chemistry (J Agric Food Chem) Vol. 71 Issue 1 Pg. 522-534 (Jan 11 2023) ISSN: 1520-5118 [Electronic] United States
• PMID: 36542783 (Publication Type: Journal Article)

Chemical References

• arabitol

Topics

• Rats
• Animals
• Mice
• Gastrointestinal Microbiome
• Insulin Resistance
• Obesity (metabolism)
• Adipose Tissue, White (metabolism)
• Diet, High-Fat
• Mice, Inbred C57BL